Sandra Boom

608 total citations
22 papers, 517 citations indexed

About

Sandra Boom is a scholar working on Pharmacology, Psychiatry and Mental health and Oncology. According to data from OpenAlex, Sandra Boom has authored 22 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 9 papers in Psychiatry and Mental health and 8 papers in Oncology. Recurrent topics in Sandra Boom's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Schizophrenia research and treatment (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Sandra Boom is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Schizophrenia research and treatment (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). Sandra Boom collaborates with scholars based in United States, Netherlands and Belgium. Sandra Boom's co-authors include Krishna Talluri, Mariëlle Eerdekens, Adriaan Cleton, Frans G. M. Rüssel, Bart Remmerie, Luc Janssens, Marc Vermeir, Nancy Van Osselaer, Stefaan Rossenu and Patrick Sterkens and has published in prestigious journals such as Biological Psychiatry, Journal of Pharmacology and Experimental Therapeutics and Clinical Pharmacology & Therapeutics.

In The Last Decade

Sandra Boom

22 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Boom United States 13 315 116 114 79 61 22 517
Katrin M. Kirschbaum Germany 13 204 0.6× 116 1.0× 80 0.7× 79 1.0× 79 1.3× 19 511
Gabriel Eckermann Germany 9 385 1.2× 149 1.3× 213 1.9× 36 0.5× 123 2.0× 24 766
R. F. Bergstrom United States 9 210 0.7× 78 0.7× 200 1.8× 55 0.7× 92 1.5× 15 584
Edward L. Mattiuz United States 10 267 0.8× 76 0.7× 143 1.3× 48 0.6× 175 2.9× 14 602
Gabriella Facciolà Italy 10 446 1.4× 171 1.5× 140 1.2× 78 1.0× 281 4.6× 11 738
Jian Fang China 11 105 0.3× 63 0.5× 80 0.7× 53 0.7× 144 2.4× 18 471
Johannes Christiansen Denmark 10 224 0.7× 100 0.9× 291 2.6× 31 0.4× 84 1.4× 17 647
G. P. Mould United Kingdom 11 126 0.4× 78 0.7× 94 0.8× 83 1.1× 82 1.3× 31 527
Jun-Sheng Wang United States 13 194 0.6× 215 1.9× 185 1.6× 199 2.5× 84 1.4× 13 632
Jeffrey Paul United States 16 188 0.6× 132 1.1× 242 2.1× 43 0.5× 171 2.8× 29 700

Countries citing papers authored by Sandra Boom

Since Specialization
Citations

This map shows the geographic impact of Sandra Boom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Boom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Boom more than expected).

Fields of papers citing papers by Sandra Boom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Boom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Boom. The network helps show where Sandra Boom may publish in the future.

Co-authorship network of co-authors of Sandra Boom

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Boom. A scholar is included among the top collaborators of Sandra Boom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Boom. Sandra Boom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boom, Sandra, Herta Crauwels, Adriaan Cleton, et al.. (2009). The influence of hepatic impairment on the pharmacokinetics of paliperidone. International Journal of Clinical Pharmacology and Therapeutics. 47(10). 606–616. 31 indexed citations
2.
Cleton, Adriaan, Krishna Talluri, J. Leempoels, et al.. (2009). No pharmacokinetic interaction between paliperidone extended‐release tablets and trimethoprim in healthy subjects. Human Psychopharmacology Clinical and Experimental. 24(7). 532–539. 26 indexed citations
3.
Boom, Sandra, Krishna Talluri, Luc Janssens, et al.. (2009). Single‐ and Multiple‐Dose Pharmacokinetics and Dose Proportionality of the Psychotropic Agent Paliperidone Extended Release. The Journal of Clinical Pharmacology. 49(11). 1318–1330. 32 indexed citations
4.
Berwaerts, Joris, Adriaan Cleton, Stefaan Rossenu, et al.. (2009). A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia. Journal of Psychopharmacology. 24(7). 1011–1018. 41 indexed citations
5.
Meulder, Marc De, Bart Remmerie, Ronald P. de Vries, et al.. (2008). Validated LC–MS/MS methods for the determination of risperidone and the enantiomers of 9-hydroxyrisperidone in human plasma and urine. Journal of Chromatography B. 870(1). 8–16. 56 indexed citations
6.
Vermeir, Marc, Bart Remmerie, Geert Mannens, et al.. (2008). Absorption, Metabolism, and Excretion of Paliperidone, a New Monoaminergic Antagonist, in Humans. Drug Metabolism and Disposition. 36(4). 769–779. 133 indexed citations
7.
Cleton, Adriaan, Krishna Talluri, Igor Francetić, et al.. (2008). 306 – Pharmacodynamics of paliperidone extended-release tablets and immediate-release risperidone in schizophrenia. Schizophrenia Research. 98. 159–159. 2 indexed citations
8.
Karlsson, Per, L. Hargarter, Sigrid Nyberg, et al.. (2007). Pharmacokinetics and dopamine d2 and serotonin 5-ht2a receptor occupancy of paliperidone in healthy subjects: two open-label, single-dose studies (PAL-115). Pharmacopsychiatry. 40(5). 17 indexed citations
9.
Vermeir, Marc, et al.. (2007). Absorption; metabolism and excretion of a single oral dose of 14c-paliperidone 1mg in healthy subjects (PAL-053). Pharmacopsychiatry. 40(5). 15 indexed citations
10.
Cleton, Adriaan, Krishna Talluri, Ann Mertens, et al.. (2006). No pharmacokinetic interaction between trimethoprim and paliperidone ER in healthy subjects. Biological Psychiatry. 59(8). 2 indexed citations
11.
Rossenu, Stefaan, An Vermeulen, Adriaan Cleton, et al.. (2006). A pharmacokinetic model to document the interconversion between the enantiomers of paliperidone. Biological Psychiatry. 59(8). 3 indexed citations
12.
Cleton, Adriaan, Stefaan Rossenu, An Vermeulen, et al.. (2006). PII-72A pharmacokinetic model to document the interconversion between Paliperidone’s enantiomers. Clinical Pharmacology & Therapeutics. 79(2). P55–P55. 19 indexed citations
13.
Vermeir, Marc, et al.. (2006). PIII-78Absorption, metabolism and excretion of a single oral dose of 14C-paliperidone 1 mg in five healthy male subjects. Clinical Pharmacology & Therapeutics. 79(2). P80–P80. 10 indexed citations
14.
Cleton, Adriaan, Krishna Talluri, J. Leempoels, et al.. (2006). PI-58No pharmacokinetic interaction between trimethoprim and paliperidone ER in healthy subjects. Clinical Pharmacology & Therapeutics. 79(2). P22–P22. 9 indexed citations
15.
Karlsson, Per, Sigrid Nyberg, Erik Mannaert, et al.. (2006). PIII-57Pharmacokinetics and dopamine D2 And serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects: Two open-label, single-dose studies. Clinical Pharmacology & Therapeutics. 79(2). P74–P74. 35 indexed citations
16.
Annaert, Pieter, et al.. (2005). In vitro study on transepithelial transport of the psychotropic compound paliperidone (PAL) across Caco-2 monolayers. Drug Metabolism Reviews. 37. 15–15. 3 indexed citations
17.
Boom, Sandra, et al.. (1998). A physiologically based kidney model for the renal clearance of ranitidine and the interaction with cimetidine and probenecid in the dog. Biopharmaceutics & Drug Disposition. 19(3). 199–208. 9 indexed citations
18.
Boom, Sandra, et al.. (1997). Saturable Urinary Excretion Kinetics of Famotidine in the Dog. Journal of Pharmacy and Pharmacology. 49(3). 288–292. 9 indexed citations
19.
Boom, Sandra & Frans G. M. Rüssel. (1993). Cimetidine uptake and interactions with cationic drugs in freshly isolated proximal tubular cells of the rat.. Journal of Pharmacology and Experimental Therapeutics. 267(3). 1039–1044. 16 indexed citations
20.
Boom, Sandra, Alfons C. Wouterse, Tom B. Vree, C. A. M. van Ginneken, & Frans G. M. Rüssel. (1993). Renal Tubular Excretion of the N4-Acetyl Metabolites of Sulphasomidine and Sulphadimethoxine in the Dog. Journal of Pharmacy and Pharmacology. 45(7). 614–617. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katrin M. Kirschbaum Breakdown of academic impact, for papers by Gabriel Eckermann Breakdown of academic impact, for papers by R. F. Bergstrom Breakdown of academic impact, for papers by Edward L. Mattiuz Breakdown of academic impact, for papers by Gabriella Facciolà Breakdown of academic impact, for papers by Jian Fang Breakdown of academic impact, for papers by Johannes Christiansen Breakdown of academic impact, for papers by G. P. Mould Breakdown of academic impact, for papers by Jun-Sheng Wang Breakdown of academic impact, for papers by Jeffrey Paul
Rankless by CCL
2026